Praxis für Rheumatologie, Gastroenterologie und Innere Medizin

At Praxis für Rheumatologie, Gastroenterologie und Innere Medizin in München, clinical research in this area focuses on systemic lupus erythematosus and other inflammatory conditions driven by immune activity. The trials are designed to evaluate new treatment options and measure whether they can better control disease activity.

• Research in systemic lupus erythematosus aimed at testing a new therapy for active disease
• Studies exploring immune-related inflammation and how it responds to treatment

These studies help assess whether emerging therapies can improve symptom control and overall disease management in people with complex autoimmune disorders.

This site also conducts trials in rheumatologic conditions affecting the joints, spine, and muscles, including rheumatoid arthritis, axial spondyloarthritis, and polymyalgia rheumatica. The research is focused on finding better ways to reduce pain, stiffness, and inflammation while improving daily function.

• Studies in moderately active rheumatoid arthritis assessing whether a new treatment can improve disease control
• Trials in early axial spondyloarthritis evaluating treatment effectiveness in patients with inflammatory back disease
• Research in polymyalgia rheumatica looking at how to optimize steroid-based treatment

Overall, the work in this therapeutic area aims to refine treatment strategies for chronic inflammatory joint and muscle diseases.

Another important research focus is psoriatic arthritis, a condition that links joint inflammation with skin and connective tissue involvement. The trials at this site are evaluating new therapies and comparing them with existing options to understand how well they control active disease.

• Multiple studies in psoriatic arthritis assessing symptom improvement and disease response
• Research examining longer-term safety and tolerability of treatment for ongoing inflammatory disease
• Trials comparing new approaches with standard care to support better treatment selection

These investigations are intended to improve both short-term disease control and longer-term treatment confidence for patients living with persistent inflammatory arthritis.